Sajal Chakraborti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Sajal Chakraborti has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Tapati Chakraborti
University of Kalyani
13 shared publicationsAmritlal Mandal
Department of Biochemistry and Biophysics
6 shared publicationsSudip Das
University of Kalyani
5 shared publicationsAnimesh Chowdhury
Department of Biochemistry and Biophysics, University of Kalyani, Kalyani, West Bengal, 741235, India
4 shared publicationsJaganmay Sarkar
University of Kalyani
4 shared publicationsNur Alam
University of Kalyani
4 shared publications
Latest Publications
- 12 September 2017
- Published by Springer Nature
- p. 607-619
Solid Support Synthesis of a Dnp-Labeled Peptide for Assay of Matrix Metalloproteinase-2
- 12 September 2017
- Published by Springer Nature
- p. 607-619
Solid Support Synthesis of a Dnp-Labeled Peptide for Assay of Matrix Metalloproteinase-2
- 12 September 2017
- Published by Springer Nature
- p. 385-395
Submitochondrial Calpains in Pathophysiological Consequences
- 12 September 2017
- Published by Springer Nature
- p. 385-395
Submitochondrial Calpains in Pathophysiological Consequences
- 14 July 2017
- Published by Springer Nature
- p. 333-374
Role of Proteases in Lung Disease: A Brief Overview
Proteases play an important role in health and disease of the lung. In the normal lungs, proteases maintain their homeostatic functions that regulate processes like its regeneration and repair. Dysregulation of proteases–antiproteases balance is crucial in the manifestation of different types of lung diseases. Chronic inflammatory lung pathologies are associated with a marked increase in protease activities. Thus, in addition to protease activities, inhibition of anti-proteolytic control mechanisms are also important for effective microbial infection and inflammation in the lung. Herein, we briefly summarize the role of different proteases and to some extent antiproteases in regulating a variety of lung diseases.
- 14 July 2017
- Published by Springer Nature
- p. 333-374
Role of Proteases in Lung Disease: A Brief Overview
Proteases play an important role in health and disease of the lung. In the normal lungs, proteases maintain their homeostatic functions that regulate processes like its regeneration and repair. Dysregulation of proteases–antiproteases balance is crucial in the manifestation of different types of lung diseases. Chronic inflammatory lung pathologies are associated with a marked increase in protease activities. Thus, in addition to protease activities, inhibition of anti-proteolytic control mechanisms are also important for effective microbial infection and inflammation in the lung. Herein, we briefly summarize the role of different proteases and to some extent antiproteases in regulating a variety of lung diseases.
- 24 February 2016
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 415 (1-2) , 13-28
Cross-talk between NADPH oxidase-PKCα-p38MAPK and NF-κB-MT1MMP in activating proMMP-2 by ET-1 in pulmonary artery smooth muscle cells
Treatment of bovine pulmonary artery smooth muscle cells with endothelin-1 (ET-1) caused an increase in the expression and activation of proMMP-2 in the cells. The present study was undertaken to determine the underlying mechanisms involved in this scenario. We demonstrated that (i) pretreatment with NADPH oxidase inhibitor, apocynin; PKC-α inhibitor, Go6976; p38MAPK inhibitor SB203580 and NF-κB inhibitor, Bay11-7082 inhibited the expression and activation of proMMP-2 induced by ET-1; (ii) ET-1 treatment to the cells stimulated NADPH oxidase and PKCα activity, p38MAPK phosphorylation as well as NF-κB activation by translocation of NF-κBp65 subunit from cytosol to the nucleus, and subsequently by increasing its DNA-binding activity; (iii) ET-1 increases MT1-MMP expression, which was inhibited upon pretreatment with apocynin, Go6976, SB293580, and Bay 11-7082; (iv) ET-1 treatment to the cells downregulated TIMP-2 level. Although apocynin and Go6976 pretreatment reversed ET-1 effect on TIMP-2 level, yet pretreatment of the cells with SB203580 and Bay 11-7082 did not show any discernible change in TIMP-2 level by ET-1. Overall, our results suggest that ET-1-induced activation of proMMP-2 is mediated via cross-talk between NADPH oxidase-PKCα-p38MAPK and NFκB-MT1MMP signaling pathways along with a marked decrease in TIMP-2 expression in the cells.
- 24 February 2016
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 415 (1-2) , 13-28
Cross-talk between NADPH oxidase-PKCα-p38MAPK and NF-κB-MT1MMP in activating proMMP-2 by ET-1 in pulmonary artery smooth muscle cells
Treatment of bovine pulmonary artery smooth muscle cells with endothelin-1 (ET-1) caused an increase in the expression and activation of proMMP-2 in the cells. The present study was undertaken to determine the underlying mechanisms involved in this scenario. We demonstrated that (i) pretreatment with NADPH oxidase inhibitor, apocynin; PKC-α inhibitor, Go6976; p38MAPK inhibitor SB203580 and NF-κB inhibitor, Bay11-7082 inhibited the expression and activation of proMMP-2 induced by ET-1; (ii) ET-1 treatment to the cells stimulated NADPH oxidase and PKCα activity, p38MAPK phosphorylation as well as NF-κB activation by translocation of NF-κBp65 subunit from cytosol to the nucleus, and subsequently by increasing its DNA-binding activity; (iii) ET-1 increases MT1-MMP expression, which was inhibited upon pretreatment with apocynin, Go6976, SB293580, and Bay 11-7082; (iv) ET-1 treatment to the cells downregulated TIMP-2 level. Although apocynin and Go6976 pretreatment reversed ET-1 effect on TIMP-2 level, yet pretreatment of the cells with SB203580 and Bay 11-7082 did not show any discernible change in TIMP-2 level by ET-1. Overall, our results suggest that ET-1-induced activation of proMMP-2 is mediated via cross-talk between NADPH oxidase-PKCα-p38MAPK and NFκB-MT1MMP signaling pathways along with a marked decrease in TIMP-2 expression in the cells.
- 16 December 2015
- Published by Springer Nature
- p. 185-193
Emerging Role of Dysadherin in Metastasis
- 11 December 2015
- Published by Springer Nature
- p. 207-226
Calcium Handling in Pulmonary Vasculature Under Oxidative Stress: Focus on SERCA
- 11 December 2015
- Published by Springer Nature
- p. 207-226
Calcium Handling in Pulmonary Vasculature Under Oxidative Stress: Focus on SERCA
- 16 November 2014
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 400 (1-2) , 107-123
Cross-talk between p38MAPK and Giα in regulating cPLA2 activity by ET-1 in pulmonary smooth muscle cells
Endothelin-1 (ET-1) is known as the most potent vasoconstrictor yet described. Infusion of ET-1 into isolated rabbit lung has been shown to cause pulmonary vasoconstriction with the involvement of arachidonic acid metabolites. Given the potency of arachidonic acid metabolites, the activity of phospholipase A2 must be tightly regulated. Herein, we determined the mechanisms by which ET-1 stimulates cPLA2 activity during ET-1 stimulation of bovine pulmonary artery smooth muscle cells. We demonstrated that (i) treatment of bovine pulmonary artery smooth muscle cells with ET-1 stimulates cPLA2 activity in the cell membrane; (ii) ET-1 caused increase in O 2 ·− production occurs via NADPH oxidase-dependent mechanism; (iii) ET-1-stimulated NADPH oxidase activity is markedly prevented upon pretreatment with PKC-ζ inhibitor, indicating that PKC-ζ plays a prominent role in this scenario; (iv) ET-1-induced NADPH oxidase-derived O 2 ·− stimulates an aprotinin sensitive protease activity due to prominent increase in [Ca2+]i; (v) the aprotinin sensitive protease plays a pivotal role in activating PKC-α, which in turn phosphorylates p38MAPK and subsequently Giα leading to the activation of cPLA2. Taken together, we suggest that cross-talk between p38MAPK and Giα with the involvement of PKC-ζ, NADPH oxidase-derived O 2 ·− , [Ca2+]i, aprotinin-sensitive protease and PKC-α play a pivotal role for full activation of cPLA2 during ET-1 stimulation of pulmonary artery smooth muscle cells.
- 16 November 2014
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 400 (1-2) , 107-123
Cross-talk between p38MAPK and Giα in regulating cPLA2 activity by ET-1 in pulmonary smooth muscle cells
Endothelin-1 (ET-1) is known as the most potent vasoconstrictor yet described. Infusion of ET-1 into isolated rabbit lung has been shown to cause pulmonary vasoconstriction with the involvement of arachidonic acid metabolites. Given the potency of arachidonic acid metabolites, the activity of phospholipase A2 must be tightly regulated. Herein, we determined the mechanisms by which ET-1 stimulates cPLA2 activity during ET-1 stimulation of bovine pulmonary artery smooth muscle cells. We demonstrated that (i) treatment of bovine pulmonary artery smooth muscle cells with ET-1 stimulates cPLA2 activity in the cell membrane; (ii) ET-1 caused increase in O 2 ·− production occurs via NADPH oxidase-dependent mechanism; (iii) ET-1-stimulated NADPH oxidase activity is markedly prevented upon pretreatment with PKC-ζ inhibitor, indicating that PKC-ζ plays a prominent role in this scenario; (iv) ET-1-induced NADPH oxidase-derived O 2 ·− stimulates an aprotinin sensitive protease activity due to prominent increase in [Ca2+]i; (v) the aprotinin sensitive protease plays a pivotal role in activating PKC-α, which in turn phosphorylates p38MAPK and subsequently Giα leading to the activation of cPLA2. Taken together, we suggest that cross-talk between p38MAPK and Giα with the involvement of PKC-ζ, NADPH oxidase-derived O 2 ·− , [Ca2+]i, aprotinin-sensitive protease and PKC-α play a pivotal role for full activation of cPLA2 during ET-1 stimulation of pulmonary artery smooth muscle cells.
- 22 February 2014
- Published by Springer Nature
- p. 115-133
Pathophysiological Aspects of Lipoprotein-Associated Phospholipase A2: A Brief Overview
- 22 February 2014
- Published by Springer Nature
- p. 115-133
Pathophysiological Aspects of Lipoprotein-Associated Phospholipase A2: A Brief Overview
- 13 November 2013
- Published by Springer Nature
- p. 49-62
Exercise and Matrix Metalloproteases in Health and Disease: A Brief Overview
- 13 November 2013
- Published by Springer Nature
- p. 49-62
Exercise and Matrix Metalloproteases in Health and Disease: A Brief Overview